3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Metastatic Castration-resistant Prostate Cancer
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
6
Sorafenib
4
Filgrastim
4
Carboplatin
4
Thiotepa
3
Radiotherapy
3
Psychiatric Rehabilitation
3
Nivolumab
3
Ipilimumab
3
Cyclophosphamide
3
sargramostim
2
ixabepilone
2
fludarabine
2
Temozolomide
2
Sirolimus
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Gene Expression Profiling
2
Etoposide
2
Drug Therapy
2
Counseling
2
Busulfan
2
Bupropion
2
Blood Specimen Collection
2
Biopsy
2
vofatamab
1
utomilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Radionuclide Imaging
×
Genitourinary
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled